CN102895501A - 一种治疗不寐的药物 - Google Patents
一种治疗不寐的药物 Download PDFInfo
- Publication number
- CN102895501A CN102895501A CN2011102117872A CN201110211787A CN102895501A CN 102895501 A CN102895501 A CN 102895501A CN 2011102117872 A CN2011102117872 A CN 2011102117872A CN 201110211787 A CN201110211787 A CN 201110211787A CN 102895501 A CN102895501 A CN 102895501A
- Authority
- CN
- China
- Prior art keywords
- radix
- insomnia
- drug
- treatment
- flavor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 29
- 206010022437 insomnia Diseases 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 229940079593 drug Drugs 0.000 title abstract 4
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 8
- 241000756943 Codonopsis Species 0.000 claims abstract description 6
- 241000411851 herbal medicine Species 0.000 claims abstract description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 230000002936 tranquilizing effect Effects 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 5
- 210000005036 nerve Anatomy 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 3
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 20
- 235000019634 flavors Nutrition 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000010685 fatty oil Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010057071 Rectal tenesmus Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 2
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- -1 rehmanin Chemical compound 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 208000012271 tenesmus Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- JZVFJDZBLUFKCA-ZXLWUMLCSA-N Chondrillasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-ZXLWUMLCSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 241001092500 Photinia x fraseri Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- JZVFJDZBLUFKCA-INYURWPISA-N Poriferasta-7,22E-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-INYURWPISA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 229940098421 anthraquinone glycoside Drugs 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗不寐的药物,属于中药制剂技术领域。它主要由党参、茯神、酸枣仁、五味子、黄连、合欢皮、夜交藤、龙齿等十八味中草药构成。本发明具有滋肾健脾,清心疏肝,清热化痰,益气和中,定志安神的作用,对失眠不寐有良好疗效,并且毒副作用小,服用简便。
Description
所属技术领域
本发明属于中药制剂技术领域。
背景技术
不寐也就是失眠,是一种常见病。现代社会,由于生活节奏加快,人们承担的生活压力越来越大,特别是现代生活中广泛存在生活工作作息时间不规律,使患失眠的人越来越多。失眠在中医上讲亦称不寐,是指入睡困难,或睡后易醒,而致睡眠时间明显减少。目前对失眠的治疗,是采用服中西药。但服中药一般疗效较差,起效较慢,而服一些西药,虽然有的效果明显,但有严重的副作用,如服西药镇静催眠类药物,虽然起效快,但有成瘾性,对肝、肾、大脑造成严重损害。
发明内容
为了克服现有技术的不足,本发明提供一种新的治疗不寐的药物。本发明具有滋肾健脾,清心疏肝,清热化痰,益气和中,定志安神的作用,对失眠不寐的治疗可以达到效果好,见效快,无毒副作用,服用简便,容易推广的目的。
本发明解决其技术问题所采用的技术方案是:
本发明由党参、黄芪、茯神、酸枣仁、柏子仁、五味子、远志、当归、石菖蒲、黄连、肉桂、生地黄、熟地黄、麦门冬、柴胡、合欢皮、夜交藤、龙齿十八味中草药构成。
本发明制剂中有关药物成份主要功能主治与配制。
本发明中的党参、性味甘、微苦、平,含淀粉,皂甙,果糖等。补气养心,健脾生津。主治脾虚泄泻,食欲不振,肺虚喘咳,自汗盗汗,津伤口渴,心悸。
本发明中的黄芪,性味甘、微温,含胆碱,甜菜碱,叶酸,氨基酸,糖类等。补气固表,托毒生肌。主治表虚自汗,盗汗,气虚血脱,脾虚泄泻,痈疽不溃或溃不收敛及一切元气不足之症。
本发明中的茯神(又名茯苓),为带有松根的茯苓,性味甘、淡、平,含茯苓酸,麦角甾醇,胆碱,组氨酸,蛋白质,卵磷脂,脂肪等。渗湿利水,安心神,益脾胃。主治失眠,健忘,心悸怔忡等症。
本发明中的酸枣仁,性味甘,平,含多种脂肪油及蛋白质,植物醇,伊百灵内脂,桦木酸,桦木酮,皂甙,维生素丙等。宁心安神,敛汗生津。主治虚烦不眠,惊悸健忘,体虚多汗,津少烦躁。
本发明中的柏子仁,性味甘,平,含脂肪油,皂甙及少量挥发油。养心,安神,润燥。主治惊悸,失眠,遗精,盗汗,便秘。
本发明中的五味子,性味酸、温,含挥发油,五味子素,苹果酸,柠檬酸,糖类,脂肪油,维生素A、C等。敛肺止泻,生津敛汗,固肾涩精。主治肺气不足,气喘咳嗽,遗精遗尿,自汗盗汗,泄泻口渴。
本发明中的远志,性味苦、辛、温,含多种三萜皂甙,远志醇,脂肪油,树脂等。益智安神,散郁豁痰,消疽肿。主治心神不安,惊悸健忘,失眠多梦,咳嗽多痰,痈疽疮肿。
本发明中的当归,性味甘、辛,含挥发油,棕榈酸,蔗糖,维生素B12,烟酸,维生素E等。补血活血,化瘀生新,调经润燥,润肠胃,温中止疼。主治血虚头疼,腰疼,心腹诸疼,大便燥结,痿痹,癓瘕,痈疽疮疡,经来腹疼,崩漏等。
本发明中的石菖蒲,性味辛、温,含挥发油,鞣质,淀粉,棕榈酸等。化痰散风,宜气开窍,解毒杀虫。主治癫狂惊痫,健忘多梦,风寒湿痹,噤口痢,外治痈咀,湿疮。
本发明中的黄连,性味苦、寒,含小蘖碱,甲基黄连碱,棕榈碱等多种生物碱。泻火燥湿,除烦解毒。主治热盛心烦,痞满,消渴,热痢腹疼,里急后重,目赤肿痛,痈肿疮毒,口疮。
本发明中的肉桂,性味辛、甘,大热,含挥发油,粘液质,鞣酸及树脂等。温中,散寒,止痛。主治命门相火不足,肢冷脉微,胃寒腹痛吐泻,腰膝冷痛,阴疽疝瘕,虚阳上浮,上热下寒。
本发明中的生地黄,性味甘、寒,含甘露醇,葡萄糖,生物碱,脂肪酸,维生素A,地黄素,梓醇等。滋阴降火,生血凉血。主治温病伤阴,大热烦渴,斑疹,消渴,血热妄行。
本发明中的熟地黄,性味甘、微苦,微温,含甘露醇,葡萄糖,生物碱,脂肪酸,维生素A,地黄素,梓醇等。滋阴补肾,补血调经。主治阴虚血少,精亏劳损,腰酸头昏,耳聋,月经不调,崩漏,须发早白。
本发明中的麦门冬,性味甘、微苦,微寒,含甾醇,氨基酸,维生素A,葡萄糖,甾体皂甙。清热除烦,生津解渴,润肺止咳。主治心烦,咽干,口渴,虚劳咳嗽,咯血,吐血,热痫伤津。
本发明中的柴胡,性味苦、微寒,含柴胡皂甙,菠菜甾醇,脂肪油,木蜡酸及挥发油等。发表和里,升阳解郁。主治寒热往来,胸满,胁痛,口苦,呕吐,头眩耳聋,疟疾,中气下陷,脱肛,月经不调,子宫下坠。
本发明中的合欢皮,性味甘,平,含合欢甙,皂甙,鞣质等。安神解郁,活血止痛,消痈肿,续筋骨。主治心神不安,忧郁失眠,肺痈吐脓,筋骨折伤,痈疸疮肿。
本发明中的夜交藤,性味甘、微苦,平,含蒽醌甙类,主要为大黄素,大黄酚或大黄素甲醚,均以结合状态存在。养心安神,袪风湿,舒经络。主治失眠,多汗,血虚身痛,痈疽,瘰疠,风疮疥癣。
本发明中的龙齿,性味甘、凉、涩,含碳酸钙,磷酸钙等。镇惊安神,除烦热。主治惊痫,癫狂,烦热不安,失眠多梦。
不寐一般有实证,虚证之分。实证多因肝郁化火,痰热内扰,心火亢盛,虚证多因心肾不交,心脾两虚及心胆气虚。但在临床上,也有相当一部分患者属于虚实夹杂之证侯,既因情志不畅,肝失调达,郁而化炎扰动心神,也因肾阴不足,劳倦思虑太过,伤及心脾,气血亏虚,神不守舍而造成失眠。本发明具有滋肾健脾,清心疏肝,清热化痰,益气和中,定志安神的作用,因而对失眠效果显著,特别是对虚实夹杂混合型失眠不寐效果更好。
本发明的有益效果是:对不寐疗效确切,特别是对虚实夹杂患者疗效良好,并且无毒副作用,服用简便。
具体实施方式
1.配方比例:党参6%、黄芪7%、茯神5.3%、酸枣仁7%、柏子仁10.6%、五味子5.3%、远志5.3%、当归5.3、石菖蒲3.5%、黄连2.4%、肉桂3.5%、生地黄5.3%、熟地黄5.3%、麦门冬5.3%、柴胡5.3%、合欢皮7%、夜交藤10.6%、龙齿3%。以上中草药总重量比为百分之百。
2.将上述十八味中草药炮制合格,提纯,浓缩,称量配齐,可加工成胶囊,片剂,颗粒,口服液等不同剂型。
病例介绍:陈××,男,58岁,河南省登封市人。一年前,因思虑过重,精神生活压力,时有失眠,入睡困难,或睡而易醒,醒后不能再睡。后因家庭纠纷,较长时间精神紧张,致失眠加重,一个多月时间几乎彻夜转侧,难以入睡,服中西药疗效不明显,只能依靠镇静催眠药物,如服舒乐安定才能入睡,并伴有头晕、心悸健忘,腰酸耳鸣、神疲肢倦,心烦易怒。查:面色无华,精神疲乏,口干津少,舌尖红,苔黄,脉细弦。诊断:不寐(心脾两虚、心肾阴虚)。用本发明汤剂治疗,每日一剂,早晚各服一次。服一剂后,头晕耳鸣减轻,较易入睡,服三剂后,可以入睡。服七剂后,各种症状消失,治愈。
Claims (1)
1.一种治疗不寐的药物,其特征是由党参、黄芪、茯神、酸枣仁、柏子仁、五味子、远志、当归、石菖蒲、黄连、肉桂、生地黄、熟地黄、麦门冬、柴胡、合欢皮、夜交藤、龙骨构成,它们的总重量比为百分之百,其中党参6%、黄芪7%、茯神5.3%、酸枣仁7%、柏子仁10.6%、五味子5.3%、远志5.3%、当归5.3、石菖蒲3.5%、黄连2.4%、肉桂3.5%、生地黄5.3%、熟地黄5.3%、麦门冬5.3%、紫胡5.3%、合欢皮7%、夜交藤10.6%、龙齿3%,以上中草药炮制合格、提纯、浓缩、称量配齐,加工成胶囊、片剂、颗粒、口服液不同剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102117872A CN102895501A (zh) | 2011-07-27 | 2011-07-27 | 一种治疗不寐的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102117872A CN102895501A (zh) | 2011-07-27 | 2011-07-27 | 一种治疗不寐的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102895501A true CN102895501A (zh) | 2013-01-30 |
Family
ID=47568187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102117872A Pending CN102895501A (zh) | 2011-07-27 | 2011-07-27 | 一种治疗不寐的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895501A (zh) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599282A (zh) * | 2013-11-22 | 2014-02-26 | 童绥君 | 一种用于治疗失眠的药物组合物 |
| CN104147350A (zh) * | 2014-09-04 | 2014-11-19 | 胡健 | 一种用于治疗失眠的中药 |
| CN104398990A (zh) * | 2014-11-30 | 2015-03-11 | 顾蔷怡 | 一种治疗失眠、心悸的中药组合物及其制备方法 |
| CN104784458A (zh) * | 2015-04-26 | 2015-07-22 | 李厚建 | 一种治疗失眠症的中药组合物 |
| CN104997923A (zh) * | 2015-08-10 | 2015-10-28 | 青岛琴诚医药技术有限公司 | 一种用于治疗失眠的药物制剂 |
| CN107789531A (zh) * | 2017-12-08 | 2018-03-13 | 辽源誉隆亚东药业有限责任公司 | 养心安神中药制剂及其制备方法 |
| CN108245638A (zh) * | 2017-12-12 | 2018-07-06 | 广州香象渡河生物科技有限公司 | 一种睡眠香及其制备方法 |
| CN112915142A (zh) * | 2021-01-28 | 2021-06-08 | 河南省中医院(河南中医药大学第二附属医院) | 一种中药刮痧介质及其制备方法 |
| CN115779031A (zh) * | 2022-11-16 | 2023-03-14 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗失眠的中药组合物 |
| CN120837571A (zh) * | 2025-09-23 | 2025-10-28 | 中国中医科学院 | 治疗艾滋病合并失眠的穴位贴敷中药组合物、穴位贴及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1229665A (zh) * | 1999-01-07 | 1999-09-29 | 赵胜国 | 一种生发剂 |
| CN101961190A (zh) * | 2010-10-20 | 2011-02-02 | 刘爱霞 | 失眠康复药枕 |
-
2011
- 2011-07-27 CN CN2011102117872A patent/CN102895501A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1229665A (zh) * | 1999-01-07 | 1999-09-29 | 赵胜国 | 一种生发剂 |
| CN101961190A (zh) * | 2010-10-20 | 2011-02-02 | 刘爱霞 | 失眠康复药枕 |
Non-Patent Citations (2)
| Title |
|---|
| 李清亚等: "中医治疗失眠症的现状", 《临床心身疾病杂志》 * |
| 焦富英等: "中医治疗失眠症研究进展", 《实用中医内科杂志》 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103599282A (zh) * | 2013-11-22 | 2014-02-26 | 童绥君 | 一种用于治疗失眠的药物组合物 |
| CN104147350A (zh) * | 2014-09-04 | 2014-11-19 | 胡健 | 一种用于治疗失眠的中药 |
| CN104398990A (zh) * | 2014-11-30 | 2015-03-11 | 顾蔷怡 | 一种治疗失眠、心悸的中药组合物及其制备方法 |
| CN104784458A (zh) * | 2015-04-26 | 2015-07-22 | 李厚建 | 一种治疗失眠症的中药组合物 |
| CN104997923A (zh) * | 2015-08-10 | 2015-10-28 | 青岛琴诚医药技术有限公司 | 一种用于治疗失眠的药物制剂 |
| CN107789531A (zh) * | 2017-12-08 | 2018-03-13 | 辽源誉隆亚东药业有限责任公司 | 养心安神中药制剂及其制备方法 |
| CN108245638A (zh) * | 2017-12-12 | 2018-07-06 | 广州香象渡河生物科技有限公司 | 一种睡眠香及其制备方法 |
| CN112915142A (zh) * | 2021-01-28 | 2021-06-08 | 河南省中医院(河南中医药大学第二附属医院) | 一种中药刮痧介质及其制备方法 |
| CN112915142B (zh) * | 2021-01-28 | 2022-01-28 | 河南省中医院(河南中医药大学第二附属医院) | 一种中药刮痧介质及其制备方法 |
| CN115779031A (zh) * | 2022-11-16 | 2023-03-14 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗失眠的中药组合物 |
| CN115779031B (zh) * | 2022-11-16 | 2023-09-26 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗失眠的中药组合物 |
| CN120837571A (zh) * | 2025-09-23 | 2025-10-28 | 中国中医科学院 | 治疗艾滋病合并失眠的穴位贴敷中药组合物、穴位贴及其制备方法 |
| CN120837571B (zh) * | 2025-09-23 | 2025-12-09 | 中国中医科学院 | 治疗艾滋病合并失眠的穴位贴敷中药组合物、穴位贴及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103239634B (zh) | 一种治疗斑秃的中药组合物 | |
| CN103550495B (zh) | 一种治疗失眠的中药组合物 | |
| CN101417086A (zh) | 一种治疗心肌缺血的中药制剂 | |
| CN101085306A (zh) | 一种治疗抑郁症的内服药剂 | |
| CN103495055A (zh) | 一种用于治疗女性内分泌失调的中药汤剂及制备方法 | |
| CN103432559A (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN102772780A (zh) | 一种治疗失眠的药物及其制备方法 | |
| CN103599403B (zh) | 一种治疗偏头痛的中药组合物及其制备方法 | |
| CN103156971A (zh) | 一种防治老年性痴呆的药物 | |
| CN103330835A (zh) | 一种治疗更年期综合症的中药组合物 | |
| CN102274425B (zh) | 一种改善睡眠质量的中药组合物 | |
| CN102406784B (zh) | 一种治疗失眠的中药组合物 | |
| CN101455795A (zh) | 一种治疗自汗的中药制剂及其制备方法 | |
| CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
| CN102091163B (zh) | 一种治疗糖尿病性心脏病的中药组合物 | |
| CN102293941B (zh) | 一种治疗糖尿病的中药组合物 | |
| CN104857414A (zh) | 一种治疗慢性单纯性鼻炎的药物组合物 | |
| CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
| CN103736001B (zh) | 一种治疗失眠的中药组合物 | |
| CN101204496B (zh) | 一种用于治疗月经不调的中成药 | |
| CN108498693A (zh) | 一种治疗失眠的中药组合物 | |
| CN105561011A (zh) | 专门用于防治哺乳期中乳汁自然流出不止的中药 | |
| CN102475843A (zh) | 一种治疗盗汗的中药制剂 | |
| CN104107304A (zh) | 一种治疗白发病的中药组合物 | |
| CN103893598A (zh) | 一种治疗失眠的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130130 |